2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma
Person to watch
Jennifer Cook
The 25-year Genentech veteran — most recently in charge of clinical operations — after a year on the job is leading early cancer diagnostics company Grail toward a potential $500 million IPO. Grail is also launching a 50,000-person study to see if its technology can detect multi ple cancer types earlier, particularly lung cancer.
Technology to watch
AI / ML
From Daphne Koller’s Insitro to Alice Zhang’s Verge Genomics Inc., artificial intelligence and machine…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Health Management | Lung Cancer | Lung Transplant | Pharmaceuticals | Study